During the trial , the mean percentage of urine samples negative for opioids was lower for patients in the taper group ( @ % -LSB- @ % CI , @ % -@ % -RSB- ) compared with those in the maintenance group ( @ % -LSB- @ % CI , @ % -@ % -RSB- ) .